s6y
Company name or ticker
Search
4D Molecular Therapeutics, Inc.
4
Kirn David: Statement of changes in beneficial ownership of securities
Filed
Wednesday, September 16, 2026
Period
Sep 14, 2026
Accession number
0001193125-26-393243
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header